Results 121 to 130 of about 22,016 (288)
Comparison of Antiepileptic Drug Levels in Sudden Unexpected Deaths in Epilepsy with Deaths from Other Causes [PDF]
Ken Opeskin +3 more
openalex +1 more source
Abstract Objective Development in seizure detection devices has focused mainly on detection performance. Yet, in order to serve their function in preventing harmful situations and even sudden unexpected death in epilepsy (SUDEP), caregivers need to respond to seizure alarms. This aspect has not been studied so far.
Anemoon T. Bosch +2 more
wiley +1 more source
Prolactin Levels in Sudden Unexpected Death in Epilepsy [PDF]
Kenneth Opeskin +2 more
openalex +1 more source
Comorbidities in the mouse model of temporal lobe epilepsy induced by intrahippocampal kainate
Abstract Objective Mesial temporal lobe epilepsy (MTLE) is generally associated with cognitive and psychiatric comorbidities. Here we examined whether similar comorbidities are observed in mice injected with kainate in the dorsal hippocampus, a model known to recapitulate many features of human MTLE, and if these comorbidities are sex dependent ...
Loan Samalens +4 more
wiley +1 more source
Sudden unexpected death in epilepsy: a series of witnessed deaths [PDF]
Yvonne Langan
openalex +1 more source
Abstract Objective Current preclinical epilepsy drug screening relies on animal models that poorly reflect human neurophysiology, leading to high failure rates in clinical translation. We aimed to establish a human in vitro model using human‐induced pluripotent stem cell (hiPSC)–derived cortical neurons cultured on multielectrode arrays (MEAs), capable
Joshua Nicholls +13 more
wiley +1 more source
Long‐term survival after adult epilepsy surgery: Mortality and predictors in a large cohort
Abstract Objective Long‐term survival data in adults undergoing surgery for drug‐resistant focal epilepsy remain limited. We examined mortality patterns and predictors in a large cohort followed for over 30 years. Methods Adults who underwent epilepsy surgery (1990–2022) were analyzed.
Giorgio Fiore +6 more
wiley +1 more source
Abstract At present, the outcomes measured and reported in clinical trials for adults with epilepsy are heterogenous and have often not been selected in consultation with people living with epilepsy. As part of a wider project developing a core outcome set for clinical trials for adults with epilepsy (the EPSET Project), a rapid review of the published
James W. Mitchell +4 more
wiley +1 more source
Abstract Objective Patients with epilepsy (PWE) are at increased risk for cardiac abnormalities, including arrhythmias, structural changes, and sudden unexpected death in epilepsy (SUDEP). Although previous studies have examined ventricular dysfunction, left atrial (LA) structural and mechanical changes remain underexplored.
Selcen Duran, Yalcin Boduroglu
wiley +1 more source
Abstract Drug development for developmental and epileptic encephalopathies (DEEs) follows different strategies on one hand including disease‐targeting precision medicine approaches considering the genetic variants and pathomechanisms in DEEs and on the other hand including therapeutic approaches with novel targets or second‐generation drug candidates ...
Heidrun Potschka, Daniel Pérez‐Pérez
wiley +1 more source

